IRCT20200105046010N14Not yet recruiting未知
Pharmacokinetic assessments of Escitalopram tablet with brand drugs (Cipralex 20mg Loundbeck A/S Denmark).
Abidi Pharmaceutical Company0 sites24 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 60 years (—)
- Sex
- Male
Inclusion Criteria
- •General health (liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
Exclusion Criteria
- •Alcohol & Drug addiction
Investigators
Similar Trials
Recruiting
Not Applicable
escitalopram in depressive patients with acute coronary artery syndromeMental and behavioral disordersKCT0000053Chonnam National University Hospital300
Completed
Phase 3
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
Completed
Phase 4
Comparison Of Two Anti Depressant Drugs In Major Depressive DisorderCTRI/2018/02/011662Government Medical College50
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Completed
Not Applicable
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorderJPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200